Login / Signup

A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 Diabetes.

Kevin CowartScott CoonNicholas W Carris
Published in: The Annals of pharmacotherapy (2023)
Bexagliflozin appears safe and effective as monotherapy and add-on pharmacological therapy for the treatment of T2D.
Keyphrases
  • combination therapy
  • open label
  • clinical trial